Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Woodworth Marshall H. Officer active across 2 companies, notably MetaVia Inc.. Aggregated, 5 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 1 March 2024. The latest transaction was filed on 23 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Woodworth Marshall H is Chief Financial Officer at MetaVia Inc. and NeuroBo Pharmaceuticals, Inc. He has 4 filings in total, and across the 4 sampled recent filings, the transactions run from 2024-03-04 to 2025-08-13, with EUR 8702 of purchases and EUR 0 of sales. The most common transaction nature is Don.